Drug recall D-0620-2018
Product
Estradiol Vaginal Inserts, USP 10 mcg, packaged in a) 8 inserts/carton (NDC 0093-3223-08) and b) 18 inserts/carton (NDC 0093-3223-97), Rx only, Teva Women's Health, Inc. Subsidiary of Teva Pharmaceuticals USA, North Wales, PA 19454.
Reason for recall
Defective Container: This recall is being initiated due to product complaints regarding difficulty in dispensing the tablet from the applicator.
Lots and codes
Lot #: a) 33812545A, 33812546A, 33812774A, Exp. 12/2018; 33812775A, Exp. 01/2019; 33812776A, 33812777A, Exp. 05/2019; 33813786A, 33813868A, Exp. 7/2019; 33813974A, 33814058A, Exp. 09/2019; 33814113A, Exp. 01/2019; b) 33812547A, 33813361A,33813676A, Exp. 1/2019
Recall details
- Recalling firm
- Teva Pharmaceuticals USA, North Wales, PA
- Quantity
- 640,486 vaginal inserts
- Distribution
- Distributed within the United States and Puerto Rico.
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 19, 2018
- Terminated
- October 15, 2019
Related products
- Estradiol – drug information
- NDC 0093-3223 Estradiol · Estradiol 10 ug/1 · Teva Pharmaceuticals USA, Inc.